Xiao Wu
Guiyang, 550023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multi-omics Analysis Reveals the Prognostic and Therapeutic Value of TGF-β Signaling-related Genes in Idiopathic Pulmonary Fibrosis.
Journal: Biochemical genetics
Published: August 31, 2024
Role of telomere dysfunction and immune infiltration in idiopathic pulmonary fibrosis: new insights from bioinformatics analysis.
Journal: Frontiers in genetics
Published: June 18, 2024
Construction and Bioinformatics Analysis of ceRNA Regulatory Networks in Idiopathic Pulmonary Fibrosis.
Journal: Biochemical genetics
Published: February 20, 2024
Comprehensive analysis of an endoplasmic reticulum stress-related gene prediction model and immune infiltration in idiopathic pulmonary fibrosis.
Journal: Frontiers in immunology
Published: October 18, 2023
A selective CB2R agonist (JWH133) protects against pulmonary fibrosis through inhibiting FAK/ERK/S100A4 signaling pathways.
Journal: BMC pulmonary medicine
Published: April 11, 2023
Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice.
Journal: Inflammation
Published: February 16, 2023
Identification of immune biomarkers associated with basement membranes in idiopathic pulmonary fibrosis and their pan-cancer analysis.
Journal: Frontiers in genetics
Published: December 02, 2022
Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK/ERK/S100A4 signalling pathway.
Journal: International immunopharmacology
Published: September 19, 2022
Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K/Akt/mTOR signaling pathway.
Journal: Scientific reports
Published: September 08, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026